Retraction
MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
Paper Information
Record ID:
36046
Journal:
Publication Date:
October 22, 2018
Retraction Date:
March 10, 2022
(3.7 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (28)
28
Total Citations8
Post-Retraction(28.6%)
20
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
5
Within 1 year
2
After 2+ years
1087
Days since retraction (latest)
Silibinin‐Loaded Nanoparticles for Drug Delivery in Gastric Cancer: In Vitro Modulating <scp>miR</scp>‐181a and <scp>miR</scp>‐34a to Inhibit Cancer Cell Growth and Migration
Mohsen Karami Fath, Parastoo Vakilinezami, Zohre Abdoli Keleshtery et al. (10 authors)
Food Science & Nutrition
Open Access
Published: Mar 2025
2 citations
2 citations
1087 days after retraction
Role of SPRY4 in health and disease
Hao Pan, Renjie Xu, Yong Zhang
Frontiers in Oncology
Open Access
Published: Apr 2024
2 citations
2 citations
767 days after retraction
Recent advances in novel miRNA mediated approaches for targeting breast cancer
Seyedeh Melika Ahmadi, Shervin Amirkhanloo, Rezvan Yazdian‐Robati et al. (8 authors)
Journal of drug targeting
Published: Jul 2023
13 citations
13 citations
499 days after retraction
RNA interference: Promising approach for breast cancer diagnosis and treatment
Elham Allahyari, Kobra Velaei, Zohreh Sanaat et al. (6 authors)
Cell Biology International
Open Access
Published: Dec 2022
11 citations
11 citations
291 days after retraction
Sprouty4 is epigenetically upregulated in human colorectal cancer
Alexei J. Stuckel, Shuai Zeng, Zhen Lyu et al. (12 authors)
Epigenetics
Open Access
Published: Nov 2022
6 citations
6 citations
251 days after retraction
miRNA: A Promising Therapeutic Target in Cancer
Amrutha Menon, Noraini Abd-Aziz, Kanwal Khalid et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Sep 2022
237 citations
237 citations
203 days after retraction
The potential of CircRNA1002 as a biomarker in hepatitis B virus-related hepatocellular carcinoma
Ying Li, Ronghua Li, Da Cheng et al. (6 authors)
PeerJ
Open Access
Published: Jun 2022
9 citations
9 citations
110 days after retraction
ST08 Altered NF-κB Pathway in Breast Cancer Cells In Vitro as Revealed by miRNA-mRNA Analysis and Enhanced the Effect of Cisplatin on Tumour Reduction in EAC Mouse Model
Snehal Nirgude, Sagar Desai, Raghunandan Mahadeva et al. (5 authors)
Frontiers in Oncology
Open Access
Published: May 2022
17 citations
17 citations
60 days after retraction
Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
Radhakrishnan Vishnubalaji, Nehad M. Alajez
Scientific Reports
Open Access
Published: Jul 2021
66 citations
66 citations
224 days before retraction
Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma
Ethan J. Brock, Ryan M. Jackson, Julie L. Boerner et al. (7 authors)
PLoS ONE
Open Access
Published: May 2021
7 citations
7 citations
286 days before retraction
A comprehensive review on oncogenic miRNAs in breast cancer
Maryam Nurzadeh, Mahsa Naemi, Shahrzad Sheikh Hasani
Journal of Genetics
Published: Mar 2021
34 citations
34 citations
372 days before retraction
Upregulation of microRNA‑181a‑5p increases the sensitivity of HS578T breast cancer cells to cisplatin by inducing vitamin D receptor‑mediated cell autophagy
JianMin Lin, Xuming Chen, Mingliang Sun et al. (10 authors)
Oncology Letters
Open Access
Published: Feb 2021
15 citations
15 citations
400 days before retraction
Potential Diagnostic and Prognostic Utility of miR-141, miR-181b1, and miR-23b in Breast Cancer
Mohamed Taha, Noha Mitwally, Ayman S. Soliman et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2020
27 citations
27 citations
481 days before retraction
Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells
Mingzhi Zhu, Fang Wang, Hailong Mi et al. (7 authors)
Cell Cycle
Open Access
Published: Oct 2020
28 citations
28 citations
496 days before retraction
LINC00675 Suppresses Cell Proliferation and Migration via Downregulating the H3K4me2 Level at the SPRY4 Promoter in Gastric Cancer
Yutian Pan, Yuan Fang, Mengyan Xie et al. (9 authors)
Molecular Therapy — Nucleic Acids
Open Access
Published: Oct 2020
15 citations
15 citations
522 days before retraction
Autophagy-mediating microRNAs in cancer chemoresistance
Yuanming Jing, Wenqing Liang, Jian Liu et al. (8 authors)
Cell Biology and Toxicology
Published: Sep 2020
37 citations
37 citations
555 days before retraction
Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
Jun Sheng Wong, Yoke Kqueen Cheah
Non-Coding RNA
Open Access
Published: Jul 2020
20 citations
20 citations
605 days before retraction
MiR-181d-5p Targets KLF6 to Improve Ischemia/Reperfusion-Induced AKI Through Effects on Renal Function, Apoptosis, and Inflammation
Yue Zhang, Chenyu Li, Guan Chen et al. (11 authors)
Frontiers in Physiology
Open Access
Published: May 2020
44 citations
44 citations
652 days before retraction
The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer
Alessia Indrieri, Sabrina Carrella, Pietro Carotenuto et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Mar 2020
136 citations
136 citations
722 days before retraction
miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis
Ke‐Jing Zhang, Yu Hu, Na Luo et al. (7 authors)
International Journal of Oncology
Open Access
Published: Feb 2020
38 citations
38 citations
749 days before retraction
Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction
Dharambir Kashyap, Harmandeep Kaur
Life Sciences
Published: Feb 2020
53 citations
53 citations
762 days before retraction
Downregulation of miR-302b is associated with poor prognosis and tumor progression of breast cancer
Jing Ma, Zhijian Zhou
Breast Cancer
Published: Nov 2019
12 citations
12 citations
848 days before retraction
Peer Review #2 of "lncRNA TMEM51-AS1 and RUSC1-AS1 function as ceRNAs for induction of laryngeal squamous cell carcinoma and prediction of prognosis (v0.1)"
Hui Lian, Jing Wang, Jialiang Zhang et al. (4 authors)
Unknown Journal
Open Access
Published: Sep 2019
912 days before retraction
Peer Review #2 of "lncRNA TMEM51-AS1 and RUSC1-AS1 function as ceRNAs for induction of laryngeal squamous cell carcinoma and prediction of prognosis (v0.2)"
Hui Lian, Jing Wang, Jialiang Zhang et al. (4 authors)
Unknown Journal
Open Access
Published: Sep 2019
912 days before retraction
lncRNA TMEM51-AS1 and RUSC1-AS1 function as ceRNAs for induction of laryngeal squamous cell carcinoma and prediction of prognosis
Lian Hui, Jing Wang, Jialiang Zhang et al. (4 authors)
PeerJ
Open Access
Published: Sep 2019
31 citations
31 citations
912 days before retraction
Peer Review #1 of "lncRNA TMEM51-AS1 and RUSC1-AS1 function as ceRNAs for induction of laryngeal squamous cell carcinoma and prediction of prognosis (v0.1)"
Hui Lian, Jing Wang, Jialiang Zhang et al. (4 authors)
Unknown Journal
Open Access
Published: Sep 2019
912 days before retraction
Ubiquitous and cell type-specific transcriptomic changes triggered by dissipation of monovalent cation gradients in rodent cells: Physiological and pathophysiological implications
Е. А. Климанова, Svetlana V. Sidorenko, Larisa V. Smolyaninova et al. (7 authors)
Current topics in membranes
Published: Jan 2019
10 citations
10 citations
1164 days before retraction
miR-4513 promotes breast cancer progression through targeting TRIM3.
Yongzhen Li, Huifang Zhu, Jian‐Qiang Wang et al. (5 authors)
PubMed
Published: Jan 2019
19 citations
19 citations
1164 days before retraction
Quick Stats
Total Citations:
28
Years Since Retraction:
3.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025